The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study
Authors:
- Tülay KamaşakTKTülay Kamaşak
- Esra SerdaroğluESEsra Serdaroğlu
- Özlem YılmazÖYÖzlem Yılmaz
- Betül Aydın KılıçBKBetül Aydın Kılıç
- Burçin G. PolatBPBurçin G. Polat
- A.DErda Yücel ŞenAŞA.DErda Yücel Şen
- Nalan ÖzenNÖNalan Özen
- Betül Diler DurgutBDBetül Diler Durgut
- Nihal YıldızNYNihal Yıldız
- Pınar Özkan KartPKPınar Özkan Kart
- 6 June 2022
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106963
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- GABAA Receptor Physiology and Its Relationship to the Mechanism of Action of the 1,5-Benzodiazepine ClobazamCNS Drugs, 2012
- Randomized, phase III study results of clobazam in Lennox-Gastaut syndromeNeurology, 2011
- Clobazam in the treatment of Lennox‐Gastaut syndromeEpilepsia, 2009
- Efficacy of Clobazam as Add-on Therapy for Refractory EpilepsyClinical Neuropharmacology, 2008
- IN VITRO AND IN VIVO INHIBITORY EFFECT OF STIRIPENTOL ON CLOBAZAM METABOLISMDrug Metabolism and Disposition, 2006
- The cognitive and behavioural effects of clobazam and standard monotherapy are comparableEpilepsy Research, 1999
- Clobazam Has Equivalent Efficacy to Carbamazepine and Phenytoin as Monotherapy for Childhood EpilepsyEpilepsia, 1998
- New Antiepileptic DrugsNew England Journal of Medicine, 1996
- Clobazam in Therapy‐Resistant Patients with Partial Epilepsy: A Double‐Blind Placebo‐Controlled Crossover StudyEpilepsia, 1987
- Clobazam as adjunctive treatment in refractory epilepsy.BMJ, 1983